oxybutynin has been researched along with donepezil in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 9 (69.23) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Axelrod, S; Bielory, L | 1 |
Cun, D; Fang, L; Liu, N; Quan, P; Zhang, Y | 1 |
Argade, NS; Dua, K; Madan, JR | 1 |
Bae, KS; Choi, HY; Choi, YK; Hong, D; Jeon, HS; Kim, SS; Kim, YH; Lee, SH; Lim, HS | 1 |
Bae, KS; Choi, HY; Hong, D; Kim, SS; Kim, YH; Lim, HS | 1 |
Deardorff, WJ; Grossberg, GT | 1 |
Arfi, S; Bhatta, RS; Mishra, PR; Mittapelly, N; Pandey, G; Tulsankar, SL | 1 |
Cha, K-; Choi, WS; Jang, SW; Kim, HJ; Kim, HS; Shin, CY; Sohn, UD | 1 |
Larkin, HD | 1 |
2 review(s) available for oxybutynin and donepezil
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Donepezil; Humans; Indans; Memantine; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Transdermal Patch | 2016 |
2 trial(s) available for oxybutynin and donepezil
Article | Year |
---|---|
Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers.
Topics: Administration, Cutaneous; Adult; Chromatography, Liquid; Donepezil; Drug Tolerance; Healthy Volunteers; Humans; Indans; Male; Middle Aged; Piperidines; Single-Blind Method; Tandem Mass Spectrometry; Transdermal Patch; Young Adult | 2015 |
Therapeutic dosage assessment based on population pharmacokinetics of a novel single-dose transdermal donepezil patch in healthy volunteers.
Topics: Adult; Cholinesterase Inhibitors; Donepezil; Healthy Volunteers; Humans; Indans; Male; Models, Biological; Piperidines; Transdermal Patch; Young Adult | 2015 |
9 other study(ies) available for oxybutynin and donepezil
Article | Year |
---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Beta2-agonists and paresthesias in multiple sclerosis.
Topics: Adrenergic beta-Agonists; Albuterol; Amantadine; Analgesics, Non-Narcotic; Androstadienes; Aromatase Inhibitors; Asthma; Bronchodilator Agents; Donepezil; Drug Therapy, Combination; Female; Fluticasone; Food Hypersensitivity; Humans; Indans; Interferons; Latex Hypersensitivity; Letrozole; Mandelic Acids; Middle Aged; Multiple Sclerosis; Nebulizers and Vaporizers; Nitriles; Nootropic Agents; Parasympatholytics; Paresthesia; Piperidines; Respiratory Function Tests; Salmeterol Xinafoate; Thyroxine; Triazoles | 2007 |
Effect of backing films on the transdermal delivery of donepezil from patches.
Topics: Administration, Cutaneous; Animals; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Cholinesterase Inhibitors; Donepezil; Excipients; Indans; Kinetics; Permeability; Pilot Projects; Piperidines; Rabbits; Skin; Skin Absorption; Solubility; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical; Transdermal Patch; Water | 2014 |
Formulation and evaluation of transdermal patches of donepezil.
Topics: Administration, Cutaneous; Animals; Chemistry, Pharmaceutical; Donepezil; Drug Evaluation, Preclinical; Indans; Piperidines; Rats; Skin Absorption; Transdermal Patch | 2015 |
In Depth Analysis of Pressure-Sensitive Adhesive Patch-Assisted Delivery of Memantine and Donepezil Using Physiologically Based Pharmacokinetic Modeling and in Vitro/in Vivo Correlations.
Topics: Administration, Cutaneous; Alzheimer Disease; Animals; Biological Availability; Donepezil; Drug Delivery Systems; Drug Liberation; Excipients; Memantine; Models, Animal; Models, Biological; Nootropic Agents; Pressure; Rats; Rats, Sprague-Dawley; Skin; Skin Absorption; Transdermal Patch | 2018 |
Pharmacological evaluation and safety of a donepezil patch.
Topics: Administration, Cutaneous; Animals; Cholinesterase Inhibitors; Donepezil; Humans; Male; Rabbits; Rats; Skin; Swine; Swine, Miniature; Transdermal Patch | 2020 |
First Donepezil Transdermal Patch Approved for Alzheimer Disease.
Topics: Administration, Cutaneous; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Humans; Indans; Nootropic Agents; Rivastigmine; Transdermal Patch | 2022 |